4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
MedKoo(授权代理)
主营:主营:抗癌化学试剂和激酶抑制剂
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > MedKoo/R112newfeatured/10mg/401780
商品详细MedKoo/R112newfeatured/10mg/401780
MedKoo/R112newfeatured/10mg/401780
MedKoo/R112newfeatured/10mg/401780
商品编号: 401780
品牌: MedKoo
市场价: ¥3000.00
美元价: 1800.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍

R112
new
featured

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#:401780

CAS#:575474-82-7

Description:R112 is a Syk inhibitor. R112 inhibited degranulation induced by anti-IgE cross-linking in mast cells (tryptase release, effective concentration for 50% inhibition [EC(50)] = 353 nmol/L) or basophils (histamine release, EC(50) = 280 nmol/L), and by allergen (dust mite) in basophils (histamine release, EC(50) = 490 nmol/L). R112 also blocked leukotriene C4 production and all proinflammatory cytokines tested. Subsequent molecular characterization indicated that R112 is an ATP-competitive spleen tyrosine kinase (Syk) inhibitor (inhibitory constant [K(i)] = 96 nmol/L).

Price and Availability

SizePriceShipping out timeQuantity
10mgUSD 150Same day
25mgUSD 250Same day
50mgUSD 450Same day
100mgUSD 750Same day
200mgUSD 950Same day
500mgUSD 1950Same day
1gUSD 29502 weeks
2gUSD 43502 weeks
5gUSD 59502 weeks
Inquire bulk and customized quantity

Pricing updated 2021-01-23.Prices are subject to change without notice.

R112, purity > 98%, is in stock. The same day shipping out after order is received. Note: the estimated shipping out time for order > 200mg may be 2 weeks.

Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 401780Name: R112CAS#: 575474-82-7Chemical Formula: C16H13FN4O2Exact Mass: 312.10225Molecular Weight: 312.3Elemental Analysis: C, 61.53; H, 4.20; F, 6.08; N, 17.94; O, 10.25

Synonym:R112; R112; R 112.

IUPAC/Chemical Name:3,3'-((5-fluoropyrimidine-2,4-diyl)bis(azanediyl))diphenol

InChi Key:TVKGTSHBQZEFEE-UHFFFAOYSA-N

InChi Code:InChI=1S/C16H13FN4O2/c17-14-9-18-16(20-11-4-2-6-13(23)8-11)21-15(14)19-10-3-1-5-12(22)7-10/h1-9,22-23H,(H2,18,19,20,21)

SMILES Code:FC1=CN=C(NC2=CC(O)=CC=C2)N=C1NC3=CC(O)=CC=C3

Technical Data

Appearance:
White to off white solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Certificate of Analysis:
View CoA: current batch, Lot#TZC61107

QC Data:
View QC data: current batch, Lot#TZC61107

Safety Data Sheet (SDS):
View Safety Data Sheet (SDS)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not soluble in water.

Shelf Life:
>5 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001

Additional Information

References

1: Rossi AB, Herlaar E, Braselmann S, Huynh S, TaylorV, Frances R, Issakani SD, Argade A, Singh R, Payan DG, Masuda ES.Identification of the Syk kinase inhibitor R112 by a human mast cellscreen. J Allergy Clin Immunol. 2006 Sep;118(3):749-55. Epub 2006 Jul28. PubMed PMID: 16950297.

2: Guyer BJ, Shimamoto SR, Bradhurst AL, Grossbard EB, Dreskin SC,Nelson HS. Mast cell inhibitor R112 is well tolerated and affectsprostaglandin D2 but not other mediators, symptoms, or nasal volumes ina nasal challenge model of allergic rhinitis. Allergy Asthma Proc. 2006May-Jun;27(3):208-13. PubMed PMID: 16913263.

3: Meltzer EO, Berkowitz RB, Grossbard EB. An intranasal Syk-kinaseinhibitor (R112) improves the symptoms of seasonal allergic rhinitis ina park environment. J Allergy Clin Immunol. 2005 Apr;115(4):791-6.PubMed PMID: 15806000.

4: Kang AK, Jenkins DJ, Wolever TM, Huff MW, Maguire GF, Connelly PW,Hegele RA. Apolipoprotein E R112; R251G: a carboxy-terminal variantfound in patients with hyperlipidemia and coronary heart disease. MutatRes. 1997 Sep;382(1-2):57-65. PubMed PMID: 9360638.  

品牌介绍
MedKoo 美帝药库公司以药物化学合成技术为核心,密切结合全球抗癌新药研发领域中的新技术、新理论、新趋势和新的发展方向,不断推出抗癌化合物新品种。 。 美帝药库MedKoo将在中国建立药物化学合成生产基地和多个现代化药物化合物存储仓库。 美帝药库的药物化合物来源于以下几个渠道:自主合成、委托化学合成、合作伙伴、和从国内外市场上选购。 MedKoo美帝药库的抗癌分子库 MedKoo的目标是打造全球规模最大、品种最多、类别最全和质量最好的小分子抗癌化合物库。MedKoo的抗癌药库将由下列5个分子库组成: (1)上市抗癌药库:该库将含有大约100个全球已批准上市的小分子抗癌化合物; (2)抗癌候选药物库:该分子库含有大约400个世界各国正在临床研究中抗癌小分子候选药物; (3)同系抗癌分子库:该分子库将含有多个化学结构类似或抗癌机制类似的分子包; (4)抗癌分子预制模块库:该库主要含有用于组建抗癌目标分子的分子模块包; (5)同位素标记抗癌分子库。